Cmed Invited to Share Its Expertise at Upcoming Industry Events

Written by Cmed

Cmed, an innovative technology-led CRO, has been invited to share its expertise in bringing innovation to the design and conduct of clinical trials at three leading industry events in February and March.

Ami Israel, Cmed’s Vice President of Clinical and Regulatory Operations, will present at eyeforpharma’s Data and Technology in Clinical Trials Summit (February 21-22, 2017, Philadelphia) in a session titled “Move towards more flexible and cost-effective trials. The Power of Technology Driven Applications”. The presentation will take place on Wednesday, February 22, at 10.15am and will explore ways to improve patient safety and compliance whilst maximizing the speed and quality of trial data. She will touch upon several themes, including how eSource and real-time clinical data analytics can improve data visibility and reduce the number of protocol violators in a trial.

Sammie Rivera, Cmed’s Senior Client Services Manager, will speak at the CROWN Congress (March 7-9, 2017, Philadelphia). She will introduce Cmed’s App based new generation clinical data suite, encapsia, in the Technology Showcase at 11:15am on Thursday March 9, 2017. The session titled “encapsia - Improving Patient Safety and Compliance, Reducing the Cost and Complexity of Clinical Trials” will highlight how a truly flexible, new seamless approach can simplify and streamline clinical trials. Attendees will also have the opportunity to visit Cmed in the exhibit hall to learn more.

In addition, Cmed will showcase the capabilities of encapsia for increasing trial efficiency, improving timelines and reducing cost at its booth during the Clinical Data Integration and Management conference (March 21-22, 2017, Princeton). Attendees will also be able to discover more about Cmed’s portfolio of CRO service offerings, which includes full service and functional service provision, such as biometrics.

To schedule a meeting with the Cmed team at these upcoming events, contact Jessi Lanuza, Associate Director, Business Development, at